DEUTSCHE BANK AG\ - POSEIDA THERAPEUTICS INC ownership

POSEIDA THERAPEUTICS INC's ticker is PSTX and the CUSIP is 73730P108. A total of 86 filers reported holding POSEIDA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.0%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of POSEIDA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$85,394
+22.0%
35,880
+129.7%
0.00%
Q1 2022$70,000
-41.2%
15,619
-10.6%
0.00%
Q4 2021$119,000
-1.7%
17,477
+5.6%
0.00%
Q3 2021$121,000
-29.2%
16,543
-3.1%
0.00%
Q2 2021$171,000
-18.6%
17,075
-22.3%
0.00%
Q1 2021$210,000
+79.5%
21,975
+106.8%
0.00%
Q4 2020$117,000
+95.0%
10,628
+57.9%
0.00%
Q3 2020$60,0006,7320.00%
Other shareholders
POSEIDA THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
SILVERARC CAPITAL MANAGEMENT, LLC 3,567,985$8,491,8042.58%
Aisling Capital Management LP 1,043,267$2,482,9751.02%
Atom Investors LP 156,168$371,6800.08%
Pentwater Capital Management LP 5,975,000$14,220,5000.08%
CORNERCAP INVESTMENT COUNSEL INC 79,709$189,7070.04%
Forefront Analytics, LLC 24,969$59,4280.03%
Callan Capital, LLC 76,559$182,2100.02%
XTX Topco Ltd 40,782$97,0610.02%
Advisory Services Network, LLC 257,271$612,3050.02%
RBF Capital, LLC 70,171$167,0070.01%
View complete list of POSEIDA THERAPEUTICS INC shareholders